
Japan's takeda aims to grow in spain
Catalan Economy
01 Mar 2010
Japanese pharmaceutical company takeda aims at strengthening its position in spain with the creation of a new subsidiary in barcelona. the japanese group will initially market its drugs for hypertension and diabetes. in the coming months, takeda also plans to launch a new treatment for osteosarcoma, which will represent a significant development in the field of cancer treatments in spain.
takeda is the largest pharmaceutical company in japan and one of the world's 20 largest pharmaceutical companies. its european operations include germany, switzerland, austria, france, britain, italy and spain. catalan agency acc1ó and its invest in catalonia unit offered advise throughout the operation.
source: la vanguardia 25/02/2010
More news and success stories.
-
21 Aug 2023
Barcelona consolidates its position as 2nd preferred location for startups in the European Union
-
17 Jul 2023
SEAT to invest 300 million euros in a battery cell assembly plant in Catalonia
-
05 May 2023
Catalonia is the second European region attracting funding for Deep Tech startups
-
02 May 2023
Catalonia's health startup ecosystem has increased investments by 87%, defying the global decline trend